Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia

Yi-Tong Li, Yu Li, Li-Na Wang, Li-Bin Huang · 2026

Read Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia by Yi-Tong Li, Yu Li, Li-Na Wang, Li-Bin Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13318783.txt.

Description

Yi-Tong Li and colleagues give a 2026 case report of relapse prevention after stem cell transplant in a young child. The patient was a five-year-old boy with high-risk acute lymphoblastic leukaemia. His cancer carried a KMT2A::USP2 fusion gene. Leftover disease signals stayed positive after induction treatment.

Blinatumomab treatment cleared the measurable disease before a half-matched transplant. Because a sensitive test still showed a trace beforehand, doctors added more cover afterwards. He received three further blinatumomab cycles plus two donor lymphocyte infusions. Only mild cytokine release syndrome appeared, with no severe nerve or breathing problems. Remission held through the reported follow-up. The authors present the combination as promising but stress that larger trials must confirm it.

Catalog record

CREATORYi-Tong Li, Yu Li, Li-Na Wang, Li-Bin Huang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE27649
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13318783

Browse the full library · About the Tower of Babel